Results 211 to 220 of about 87,437 (368)

Uncommon Evolution From Acute Myeloid Leukaemia to JAK2‐Mutated Myeloproliferative Neoplasm: Evidence of Clonal Persistence and Divergence From TET2/SRSF2‐Mutated Haematopoietic Progenitors

eJHaem, Volume 6, Issue 5, October 2025.
ABSTRACT Background The emergence of JAK2‐mutated myeloproliferative neoplasms (MPNs) after remission from acute myeloid leukaemia (AML) is exceedingly rare. Case Description This case series describes two patients who developed JAK2‐mutated MPNs years after achieving AML remission, each retaining persistent TET2 and SRSF2 mutations while losing AML ...
Mark Anthony Turingan, Ehsan Bahrami Hezaveh, Cuihong Wei, Verna Cheung, Dawn Maze, Hong Chang   +5 more
wiley   +1 more source

Plasma Concentration of Cytosine Arabinoside (Ara-C) in the Eldery Patients with Hematological Malignancy Treated by Ara-C or Cytarabine Ocfosfate (SPAC).

, 1995
Hiroyuki Tsutsumi, T Kumakawa, Masami Yokota Hirai, Masayuki Kikukawa, Y. Ben Arie, Mayumi Mori, H Kodo, N. Nakamura, Y Murai, Ryuta Mizutani   +9 more
openalex   +2 more sources

The Anticancer Drug Cytarabine Does not Interact with the Human Erythrocyte Membrane [PDF]

, 2003
Mario Suwalsky, Pedro Hernández, Fernando Pardo‐Manuel de Villena, Carlos P. Sotomayor   +3 more
openalex   +1 more source

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti‐B4‐blocked ricin or high‐dose cytarabine [PDF]

, 2003
Ted P. Szatrowski, Richard K. Dodge, Carol Reynolds, Carol A. Westbrook, Stanley R. Frankel, Jeffrey Sklar, Carleton C. Stewart, David D. Hurd, Jonathan E. Kolitz, E Vélez-García, Richard M. Stone, Clara D. Bloomfield, Charles A. Schiffer, Richard A. Larson   +13 more
openalex   +1 more source

Low survival in younger adults with Acute Myeloid Leukemia (AML) in Tanzania linked to high disease burden and socioeconomic factors. [PDF]

PLoS One
Munroe M, Chamba C, Yonazi M, Mahfudh S, Mawalla W, Mbelekwa K, Kaaya G, Mwakichako R, Mshiu J, Lyimo M, Ally M, Nasser A.   +11 more
europepmc   +1 more source

Cytarabine and Cardiac Failure [PDF]

American Journal of Hematology, 1992
openaire   +2 more sources

Neuroleukemiosis Masquerading as Drug Toxicity in an Adolescent With Refractory AML

American Journal of Hematology, Volume 100, Issue 10, Page 1853-1858, October 2025.
Nia Choi, Deborah Schady, Tim Lotze, Jill Ann Jarrell, Alexandra Rodriguez‐Hernandez, Sandra Aziz, Karen K. Moeller, Joanna S. Yi, Suzanne Woodbury, Andrea N. Marcogliese, Zoann E. Dreyer, Eric S. Schafer   +11 more
wiley   +1 more source

Recent Advancements in Graphene Quantum Dot‐Based Bioimaging and Drug Delivery Systems

MedComm, Volume 6, Issue 10, October 2025.
This article reviews recent advancements and the roles of GQDs in healthcare, with a particular focus on different synthesis methods for GQDs, including top‐down and bottom‐up approaches. It also examines the biological, optical, and toxicological attributes of GQDs, as well as their applications in bioimaging and drug delivery.
Sachin Kadian, Shubhangi Shukla, Amit K. Yadav, Brahamdutt Arya, Sushant Sethi, Vishal Chaudhary, Roger Narayan   +6 more
wiley   +1 more source

A Critical Case of Chronic Eosinophilic Leukemia: Diagnostic Criteria and Response to Cytarabine. [PDF]

Case Rep Oncol Med
Cruz-Acevedo AK, Pérez-Campos EL, Hernández-Huerta MT, Cruz-Reyes M, López-Matías J, Mayoral LP, Cruz-Hernández V.   +6 more
europepmc   +1 more source

Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia

, 2001
Brynjar Foss, Elling Ulvestad, Tor Hervig, Øystein Bruserud   +3 more
openalex   +1 more source